Lexicon Pharmaceuticals
LXRX
LXRX
98 hedge funds and large institutions have $357M invested in Lexicon Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 86 → 98 (+12)
1.66% more ownership
Funds ownership: 79.42% → 81.08% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
98
Holding in Top 10
1
Calls
$287K
Puts
$87K
Top Buyers
| 1 | +$44.6M | |
| 2 | +$8.67M | |
| 3 | +$5.02M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
+$4.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.2M |
Top Sellers
| 1 | -$958K | |
| 2 | -$720K | |
| 3 | -$558K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$484K |
| 5 |
D.E. Shaw & Co
New York
|
-$442K |